awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26750748-73550102-2819-44AA-B63C-956C38BB3ACF
Q26750748-73550102-2819-44AA-B63C-956C38BB3ACF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26750748-73550102-2819-44AA-B63C-956C38BB3ACF
How do the results of the RADIANT trials impact on the management of NET patients? A systematic review of published studies
P2860
Q26750748-73550102-2819-44AA-B63C-956C38BB3ACF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26750748-73550102-2819-44AA-B63C-956C38BB3ACF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
84980eb0180be1ab04243eecd8e397c79c415dc9
P2860
Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study